Can You Use Your HSA or FSA for Compounded Semaglutide and Tirzepatide? 2026 Guide

Yes. HSA and FSA funds can be used for compounded semaglutide and tirzepatide when prescribed by a licensed physician for a diagnosed medical condition such as obesity, type 2 diabetes, or overweight with a qualifying comorbidity. The IRS does not distinguish between compounded and brand-name prescription medications in its eligibility framework — the test is medical necessity tied to a physician diagnosis, not FDA approval status. The 2026 FSA contribution limit is $3,300. The HSA contribution limit is $4,300 individual and $8,550 family.

HSA and FSA eligibility for compounded semaglutide and tirzepatide is one of the most practically important topics for AHC patients — and one of the most widely misunderstood. Most people either don’t know their GLP-1 program qualifies, or they get their first claim denied and assume the medication is permanently ineligible.

Neither is correct. This guide gives you the exact IRS rules, the documentation that protects your claim, the contribution limits for 2026, and why AHC’s physician-prescribed program is structured in a way that supports HSA and FSA eligibility from the first payment.

The IRS Rule That Makes Compounded Semaglutide HSA and FSA Eligible

IRS Publication 502 defines qualified medical expenses eligible for tax-advantaged spending. The relevant rule is Section 213(d) of the Internal Revenue Code, which covers prescription medications prescribed by a licensed physician to treat a specifically diagnosed disease or medical condition.

Key points of the IRS standard:

• The medication must be prescribed by a licensed healthcare provider — a valid prescription is required.
• The prescription must be tied to a diagnosed medical condition — not a general desire to lose weight.
• The IRS does not require FDA approval of the specific formulation — compounded and brand-name prescription medications are treated identically under Publication 502.
• Cosmetic weight loss without a diagnosed condition does not qualify — the diagnosis is the critical factor.

Medical Conditions That Qualify for HSA and FSA Use with GLP-1 Medications

The Difference Between HSA and FSA Accounts

Health Savings Account (HSA)

• Available only with a high-deductible health plan (HDHP).
• 2026 contribution limit: $4,300 individual, $8,550 family, plus $1,000 catch-up for age 55+.
• Funds roll over year to year — they never expire.
• Portable — the account stays with you even if you change employers or insurance.
• Triple tax advantage: contributions are tax-deductible, growth is tax-free, withdrawals for qualified expenses are tax-free.

Flexible Spending Account (FSA)

• Available through most employer benefit plans — does not require an HDHP.
• 2026 contribution limit: $3,300 per year.
• Use-it-or-lose-it: most FSA funds expire at the end of the plan year (some plans have a grace period or limited rollover).
• Full annual election available on day one of the plan year — useful for large early-year expenses like GLP-1 startup costs.
• FICA savings: FSA salary deductions reduce Social Security and Medicare tax in addition to income tax.

The Documentation You Need to Protect Your Claim

Most GLP-1 HSA and FSA claims are denied not because the medication is ineligible, but because the documentation is incomplete or the prescription is coded in a way that appears cosmetic rather than medical.

Essential Documents to Keep on File

• Valid prescription from your AHC licensed physician, clearly tied to the diagnosed medical condition being treated.
• Itemized receipt from the compounding pharmacy showing medication name, quantity, date, and cost.
• Letter of Medical Necessity (LMN) from your physician — not always required but prevents the most common denial reasons.
• Documentation of your qualifying diagnosis in your medical records — this is what the IRS would examine in an audit.

What AHC’s Program Provides

AHC’s physician evaluation process documents your diagnosis and treatment rationale as part of the standard intake. Every AHC patient receives a valid physician prescription tied to a documented medical evaluation. AHC partner pharmacies issue itemized receipts appropriate for HSA and FSA reimbursement. If your plan administrator requests additional documentation, your AHC provider can issue an LMN.

How to Pay: Direct Payment vs Reimbursement

Direct HSA or FSA Card Payment

Some HSA and FSA administrators allow direct card payment at checkout for GLP-1 medications. If your card is accepted at the pharmacy or telehealth provider, you can pay directly without submitting a separate reimbursement claim.

Reimbursement Route

If your card is declined (which can happen because some card processors restrict certain merchant category codes, not because the expense is ineligible), pay out of pocket and submit a reimbursement claim through your plan administrator using your prescription and itemized receipt. There is no deadline for HSA reimbursement — you can pay out of pocket today and reimburse yourself years later, letting your HSA balance grow in the interim.

The Tax Savings Calculation: Why HSA and FSA Matter for GLP-1 Patients

For someone in the 22% federal tax bracket with a 5% state income tax rate and FICA taxes, using an HSA to pay for a $169 monthly tirzepatide prescription reduces the effective cost to approximately $114 per month — a 33% discount on every refill through tax savings alone. Over 12 months of tirzepatide therapy at AHC pricing, that represents approximately $660 in tax savings that would otherwise go to federal and state tax.

Frequently Asked Questions

1. Is compounded semaglutide HSA eligible?

Yes. Compounded semaglutide qualifies as an HSA eligible expense when prescribed by a licensed physician for a diagnosed medical condition such as obesity, type 2 diabetes, or overweight with a qualifying comorbidity. The IRS does not distinguish between compounded and brand-name prescriptions in its eligibility framework under Publication 502.

2. Can I use my FSA for tirzepatide?

Yes, under the same conditions. Tirzepatide prescribed by a licensed physician for a diagnosed condition qualifies as a flexible spending account eligible expense. The 2026 FSA contribution limit is $3,300. Keep your prescription and itemized pharmacy receipt as documentation.

3. What if my HSA card is declined at the pharmacy?

A declined HSA or FSA card does not mean the expense is ineligible. Card declines at GLP-1 providers often occur because of merchant category code restrictions, not eligibility. Pay out of pocket and submit a reimbursement claim to your plan administrator with your prescription and itemized receipt. HSA reimbursements have no deadline — you can claim the expense at any point after it occurs.

4. Do I need a Letter of Medical Necessity for my GLP-1 claim?

Not always. Many HSA and FSA plans approve GLP-1 claims automatically with a valid prescription. However, some plans request a Letter of Medical Necessity — particularly for compounded medications or for prescriptions where the documented indication is obesity rather than diabetes. Getting an LMN from your AHC provider at your first visit is a low-effort protection against future claim issues.

5. What is the 2026 HSA contribution limit?

The 2026 HSA contribution limit is $4,300 for individual coverage and $8,550 for family coverage. Individuals age 55 or older can contribute an additional $1,000 catch-up contribution. The FSA contribution limit for 2026 is $3,300.

Start Your AHC Evaluation — Your HSA and FSA Can Help Pay

AHC’s physician-prescribed GLP-1 programs are structured to support HSA and FSA eligibility from your first payment. Compounded semaglutide from $129/month. Compounded tirzepatide from $169/month. Flat-rate pricing at every dose tier. Begin your medical evaluation.

Medical Disclaimer: Compounded semaglutide and tirzepatide are not FDA-approved and have not been evaluated for safety, efficacy, or quality by the FDA. All clinical services are provided by independently contracted, U.S.-licensed clinicians. Individual results vary. This content is for informational purposes only and does not constitute medical advice.